| This is thetalk page for discussingWikiProject Pharmacology and anything related to its purposes and tasks. |
|
| Archives (index):1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19Auto-archiving period:3 months |
| This project page does not require a rating on Wikipedia'scontent assessment scale. It is of interest to the followingWikiProjects: | ||||||||
| ||||||||
| WikiProject Pharmacology was featured ina WikiProject Report in theSignpost on 17 January 2009. |
Archives |
|
This page has archives. Sections older than90 days may be auto-archived byLowercase sigmabot III if there are more than 10. |
Please add reliable sources to this stub.Bearian (talk)20:51, 29 July 2025 (UTC)[reply]
The recently created pageEvent-driven pharmacology appears to be LLM written. While there are no obvious DOI errors, it needs an expert check that the claims in the article are really supported by the sources.Ldm1954 (talk)10:17, 3 October 2025 (UTC)[reply]
You are invited to join the discussion atTemplate talk:R from drug trade name § Generic or nonproprietary name instead of INN. —Myceteae🍄🟫(talk)03:43, 19 October 2025 (UTC)[reply]
I have proposed an amendment to chemical naming policieshere at WikiProject Chemicals. This proposal substantially concerns drug-related articles. Here is the TL;DR:"Propose amending chemical naming policies to allow use of page titles with format "<acronym> (<disambig term>)", e.g., "DOM (psychedelic)". Current policies/standards do not allow this. The proposal is because oftentimes the acronyms are essentially the common/trivial name and because this proposed format is a good solution for very long, technical, and unrecognizable chemical article titles."
I'm cross-posting this proposal here to increase attention and input on the matter. Thank you. –AlyInWikiWonderland (talk,contribs)22:53, 26 October 2025 (UTC)[reply]
I just created a brief article forPremethylenomycin C lactone. Would appreciate any help from members of this project.Thriley (talk)05:20, 13 November 2025 (UTC)[reply]
Hi! I'm a COI editor for Amgen through my employer, Porter Novelli. Reaching out because I've proposed some updates to build out theOlpasiran article stub on thearticle talk page. I'd appreciate any feedback. Thanks for your time!Mary Gaulke (talk)16:19, 17 November 2025 (UTC)[reply]
A range of stub/start pages about obscure drugs have extensive binding affinity tables, but little text content in them. This leads to the problem of those tables colliding with See also/References sections and being generally distruptive visually. See:5-MeO-2-TMT
TLDR: Are scrollable binding affinity tables something that could be allowed under certain circumstances? If so then which approach would be preferred and under what conditions?
My idea of fixing this issue without having to cut off data, describing everything inline, or adding unnecessary padding is to introduce a vertical scrollable table with a sticky header and footer.My sandbox currently contains a demo of how I think it should look like and behave.
The issue with this solution is that I'm not sure if it's possible to make it fully work natively. What I've sketched out breaks the visual editor and is generally far from perfect (visual bug at the bottom, utilising thicker than normal borders). Existing templates such asTemplate:Sticky table start don't allow for float and therefore text wrapping. Seemingly the approach of creating a custom template should fix all of the above, but this seems like a pretty narrow case scenario overall.Wσlrεη⎇ (talk)14:33, 18 November 2025 (UTC)[reply]
Hello, I'm an employee at Eli Lilly and Company. I recently posted an edit request to make a change to theTirzepatide article. I won't lay out all the details here, but essentially there's a passage in theMeta-analysis section of the article that I believe is misplaced. For further details, please follow this link to myedit request. Thank you in advance to anyone who takes the time to help out!JWatLilly (talk)17:25, 18 November 2025 (UTC)[reply]
Hello. Long time reader, beginner contributor.
The only thing I could find on Steady State isthis. I feel like the concept of stead state in pharmacokinetics is important enough to have it's own article. What do others think?Profitofpan (talk)01:59, 19 November 2025 (UTC)[reply]
Amino acid has been nominated for a good article reassessment. If you are interested in the discussion, please participate by adding your comments to thereassessment page. If concerns are not addressed during the review period, the good article status may be removed from the article.Z1720 (talk)15:56, 22 November 2025 (UTC)[reply]